Virtus ETF Advisers LLC Ascendis Pharma A/S Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,676 shares of ASND stock, worth $409,374. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,676
Previous 2,576
3.88%
Holding current value
$409,374
Previous $384,000
4.17%
% of portfolio
0.16%
Previous 0.19%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.55 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$846 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$781 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$681 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$670 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.54B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...